“…Gynecological cancers (GCs), primarily comprising ovarian cancer (OC), endometrial cancer (EC, also known as uterine cancer), and cervical cancer (CC), present a significant global public health concern with profound implications for women's health and quality of life, leading to substantial disease burden. The high mortality rate and poor prognosis associated with these cancers have imposed significant pressure for effective prevention and management strategies [1] . According to the 2020 global cancer statistics, the new cases of OC, CC and EC were 313,959, 604,127, and 417,367, the new deaths were 207,252, 341,831, and 97,370, respectively [2] .…”